Unknown

Dataset Information

0

Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.


ABSTRACT: Point mutations at Arg132 of the cytoplasmic NADP(+)-dependent isocitrate dehydrogenase 1 (IDH1) occur frequently in gliomas and result in a gain of function to produce the "oncometabolite" D-2-hydroxyglutarate (D-2HG). The mutated IDH1 allele is usually associated with a wild-type IDH1 allele (heterozygous) in cancer. Here, we identify 2 gliomas that underwent loss of the wild-type IDH1 allele but retained the mutant IDH1 allele following tumor progression from World Health Organization (WHO) grade III anaplastic astrocytomas to WHO grade IV glioblastomas. Intratumoral D-2HG was 14-fold lower in the glioblastomas lacking wild-type IDH1 than in glioblastomas with heterozygous IDH1 mutations. To characterize the contribution of wild-type IDH1 to cancer cell D-2HG production, we established an IDH1-mutated astrocytoma (IMA) cell line from a WHO grade III anaplastic astrocytoma. Disruption of the wild-type IDH1 allele in IMA cells by gene targeting resulted in an 87-fold decrease in cellular D-2HG levels, showing that both wild-type and mutant IDH1 alleles are required for D-2HG production in glioma cells. Expression of wild-type IDH1 was also critical for mutant IDH1-associated D-2HG production in the colorectal cancer cell line HCT116. These insights may aid in the development of therapeutic strategies to target IDH1-mutated cancers.

SUBMITTER: Jin G 

PROVIDER: S-EPMC3548957 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.

Jin Genglin G   Reitman Zachary J ZJ   Duncan Christopher G CG   Spasojevic Ivan I   Gooden David M DM   Rasheed B Ahmed BA   Yang Rui R   Lopez Giselle Y GY   He Yiping Y   McLendon Roger E RE   Bigner Darell D DD   Yan Hai H  

Cancer research 20121130 2


Point mutations at Arg132 of the cytoplasmic NADP(+)-dependent isocitrate dehydrogenase 1 (IDH1) occur frequently in gliomas and result in a gain of function to produce the "oncometabolite" D-2-hydroxyglutarate (D-2HG). The mutated IDH1 allele is usually associated with a wild-type IDH1 allele (heterozygous) in cancer. Here, we identify 2 gliomas that underwent loss of the wild-type IDH1 allele but retained the mutant IDH1 allele following tumor progression from World Health Organization (WHO) g  ...[more]

Similar Datasets

| S-EPMC3772177 | biostudies-literature
| S-EPMC6359963 | biostudies-literature
| S-EPMC9637171 | biostudies-literature
| S-EPMC4704134 | biostudies-literature
| S-EPMC7803555 | biostudies-literature
| S-EPMC4791257 | biostudies-literature
| S-EPMC5881177 | biostudies-literature
| S-EPMC4916649 | biostudies-literature
| S-EPMC6934292 | biostudies-literature
| S-EPMC9435503 | biostudies-literature